RPG Life Sciences Limited (NSEI: RPGLIFE)
Health Care · Pharmaceuticals · IN
Rs2,636.60
-5.24% today · +12.3% 1Y
RPG Life Sciences Limited (NSEI: RPGLIFE) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $455.76M and employs 1,366 people.
Over the last twelve months the share price has gained 12.3%, trading between 1.73K and 3.08K.
Tweenvest scores RPG Life Sciences Limited across four factors: quality 84/100, value 36/100, growth 64/100, dividend 76/100. Its strongest factor is quality.
RPGLIFE price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $455.76M
- Revenue (TTM)
- $77.66M
- P/E
- 36.45
- EPS
- 72.33
- Dividend yield
- 0.91%
- Beta (5Y)
- -0.20
- 52-week high
- Rs3,082.00
- 52-week low
- Rs1,733.00
- Avg volume (3M)
- —
- Shares outstanding
- 16.54M
- Employees
- 1,366
- Next earnings
- —
About RPG Life Sciences Limited
RPG Life Sciences Limited operates as a fully integrated pharmaceutical enterprise, engaged in the development, production, and commercialization of branded drug formulations, generic medications, and synthetic active pharmaceutical ingredients (APIs) for both the Indian and global markets. The company provides synthetic APIs for diverse medical applications, including immunosuppression, psychiatric conditions, cardiac health (anti-anginals), parasitic infections (anthelmentics), seizure management (anticonvulsants), and muscle spasm relief (antispasmodics). While its generics portfolio primarily centers on immunosuppressant treatments, its finished dosage formulations address a wide spectrum of therapeutic areas, such as nephrology, rheumatology, oncology, gastroenterology, cardiovascular health, diabetology, orthopedics, neuropsychiatry, and respiratory conditions, among many others. Established in 1968 with its headquarters in Mumbai, India, the company adopted its current name in February 2008, having previously been known as RPG Pharmaceuticals Limited. RPG Life Sciences Limited functions as a subsidiary of Nucleus Life Trust.
- ISIN
- INE105J01010
- Founded
- 1968
- Listed since
- Aug 12, 2002
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,249.22 | -0.49% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $151.00 | -1.02% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.95 | -0.43% |
Figures last refreshed Aug 18, 2026.